Megibow A J, Jacob G, Heiken J P, Paulson E K, Hopper K D, Sica G, Saini S, Birnbaum B A, Redvanley R, Fishman E K
Department of Radiology, New York University Medical Center, 550 First Ave., Rm. HW 205, New York, NY 10016, USA.
AJR Am J Roentgenol. 2001 Mar;176(3):583-9. doi: 10.2214/ajr.176.3.1760583.
The purpose of our study was to determine the minimum optimal dose of IV contrast medium for helical CT that can preserve image quality while reducing cost.
Four hundred sixty-three patients from six centers were enrolled in a prospective trial in which patients were randomized into one of four weight-based dose categories of iopromide, 300 mg I/mL: 1.25, 1.50, 1.75, and 2.0 mL/kg. Six of 463 patients were excluded from analysis. A radiologist at each center who was unaware of the volume of contrast medium administered determined whether the scans were acceptable. The responses were analyzed by dose, in aggregate, and by weight. Enhancement values (in Hounsfield units) in regions of interest in the liver, pancreas, aorta, and kidneys were obtained at a single time during the scan. The participating radiologist was unaware of these values. Finally, three additional nonparticipating site observers assessed the images for acceptability, diagnostic quality, and overall level of confidence. A cost model comparing incurred charges in using 150 or 100 mL, or 1.5 mL/kg, of low osmolality contrast medium was developed from experience in an additional 303 patients.
We found no clinically significant difference in acceptability of scans at doses greater than 1.5 mL/kg. However, significant variability occurred among the centers. The use of 1.5 mL/kg led to a savings of $9927.16 for 303 patients when compared with the use of 150 mL at list price. The cost is the same for 1.5 mL/kg or use of 100 mL of contrast medium.
A weight-based dose at 1.5 mL/kg of low osmolality contrast medium can provide acceptable scans in most patients, with a significant cost savings.
我们研究的目的是确定螺旋CT静脉注射造影剂的最小最佳剂量,既能保持图像质量又能降低成本。
来自六个中心的463例患者参加了一项前瞻性试验,患者被随机分为碘普罗胺(300mg I/mL)基于体重的四个剂量组之一:1.25、1.50、1.75和2.0 mL/kg。463例患者中有6例被排除在分析之外。每个中心的一名放射科医生在不知道所注射造影剂体积的情况下确定扫描是否可接受。对反应按剂量进行总体分析,并按体重进行分析。在扫描期间的单个时间点获取肝脏、胰腺、主动脉和肾脏感兴趣区域的增强值(以亨氏单位计)。参与的放射科医生不知道这些值。最后,另外三名未参与的现场观察者评估图像的可接受性、诊断质量和总体信心水平。根据另外303例患者的经验建立了一个成本模型,比较使用150或100 mL或1.5 mL/kg低渗造影剂的费用。
我们发现剂量大于1.5 mL/kg时扫描的可接受性在临床上无显著差异。然而,各中心之间存在显著差异。与按标价使用150 mL相比,对于303例患者,使用1.5 mL/kg可节省9927.16美元。1.5 mL/kg或使用100 mL造影剂的成本相同。
对于大多数患者,基于体重的1.5 mL/kg低渗造影剂剂量可提供可接受的扫描,同时显著节省成本。